We read with great interest the published results of the RADIOSA trial by Giulia Marvaso and colleagues.1 This well designed ...

Scientists conducting medical research are facing an existential crisis: Layoffs and budget cuts pushed by President Trump ...

June brought major prostate cancer updates, and CURE is sharing the latest FDA approvals, label expansions, and emerging data ...

Esophageal adenocarcinoma (EAC), one of two major forms of esophageal cancer, is the sixth most deadly cancer worldwide for ...

The EpiSwitch PSE next generation blood test uses advances in technology to identify prostate cancer, the most common form of ...

The test uses machine learning to analyze biomarkers and clinical features to determine prostate cancer aggressiveness.

A highly expensive, revolutionary treatment for recurrent prostate cancer is for the first time in Australia available at a ...

Imagine a stadium packed with 75,000 fans, all wearing green and white jerseys—except one person in a solid green shirt.